Roche Pharmaceuticals Asia Pacific says that Dr Christiane Hamacher has assumed the role of head of Asia Pacific (APAC), joining Swiss pharma giant Roche’s global leadership team 1 November 2016
French biotech firm Erytech Pharma today announced the appointments of Dr Alexander Scheer, as the company’s chief scientific officer and Jean-Sébastien Cleiftie, as chief business officer. 27 October 2016
Swiss drug developer EffRx Pharmaceuticals today said it has named Lorenzo Bosisio appointed as chief executive effective July 1st, 2016. 12 October 2016
The board of directors of the Swiss Galenica Group has designated Stefan Schulze, currently chief executive of group company Vifor Fresenius Medical Care Renal Pharma (VFMCRP), as chief operating officer and president of the executive committee of Vifor Pharma. 6 October 2016
Astellas Pharma has appointed Steven Benner as senior vice president and therapeutic area head for oncology, and promoted Anne Keating to vice president of clinical science for oncology, within the company's development organization. 6 October 2016
Santhera Pharmaceuticals has appointed Kristina Timdahl as chief medical officer and head of development and a member of the executive management with effect from January 1, 2017. 5 October 2016
Robert Mulroy, the chief executive of USA-based Merrimack Pharmaceuticals has resigned after 17 years in the role as the company undergoes a major restructuring which will see its workforce cut by 22%. 4 October 2016
UK pharma major GlaxoSmithKline today announced that Brian McNamara has been appointed chief executive of GSK’s Consumer Healthcare division effective immediately. 29 September 2016
Family-owned Italian pharma company Zambon has appointed Roberto Tascione as its new chief executive to drive the business on a global scale. 20 September 2016
GlaxoSmithKline’s decision to appoint Emma Walmsley as chief executive is a clear commitment to past strategy but an acknowledgement that a fresh, and arguably more commercially astute, approach is required to return the company to growth. 20 September 2016
Alnylam Pharmaceuticals has announced two key appointments to its senior leadership team, expanding the breadth of talent and experience as the company prepares for commercialization of its pipeline and global expansion. 20 September 2016
GlaxoSmithKline today announces that Emma Walmsley, currently chief executive of GSK’s Consumer Healthcare division, is appointed GSK CEO designate and will succeed Sir Andrew Witty as GSK CEO. 20 September 2016
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Structure Therapeutics, a specialist in small molecule treatments for metabolic and pulmonary diseases, has announced key leadership appointments. 18 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
Under pressure from certain shareholders, autoimmune diseases specialist Aurinia Pharmaceuticals on Friday said it has restructured its board of directors. 14 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
California’s Lykos Therapeutics is still trying to regroup after being rocked by the US Food and Drug Administration’s (FDA) rejection of midomafetamine (MDMA) capsules for the treatment of post-traumatic stress disorder (PTSD). 6 September 2024
Biosimilar-focused biopharmaceutical company and contract development and manufacturing organization (CDMO) Tanvex BioPharma has named Stephen Lam its new chief executive (CEO). 5 September 2024
Novocure (Nasdaq: NVCR) has announced that chief executive Asaf Danziger will retire at the end of 2024, with current chief financial officer Ashley Cordova set to succeed him as CEO. 4 September 2024